Akero's success in reversing cirrhosis follows that of Madrigal, making analysts and investors bullish on drugs to treat ...

Grandmother of five Michelle Hayward was shocked when she was told she had irreversible liver damage from years of overeating ...

A recent study from MedUni Vienna found that as portal hypertension worsens, inflammation in the body also increases. This means that people with severe liver disease not only have high blood pressure ...

Future research is needed to study the new generation of anti-obesity medications and whether they can provide similar ...

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

Akero Therapeutics announced statistically significant results from a Phase 2b trial of efruxifermin this week, a fibroblast ...

(ETNB) stock jumped 40% Monday, stoked by positive data for Akero's (AKRO) drug efruxifermin in the treatment of compensated ...

A Cleveland Clinic study reveals that bariatric surgery significantly reduces the risk of serious liver complications in ...

Multidisciplinary care is needed to ensure positive maternal and fetal health outcomes, especially in complex or high-risk ...